260 related articles for article (PubMed ID: 31404602)
21. Development of a nanoliposomal formulation of erlotinib for lung cancer and in vitro/in vivo antitumoral evaluation.
Zhou X; Tao H; Shi KH
Drug Des Devel Ther; 2018; 12():1-8. PubMed ID: 29296076
[TBL] [Abstract][Full Text] [Related]
22. Application of Box-Behnken experimental design for the formulation and optimisation of selenomethionine-loaded chitosan nanoparticles coated with zein for oral delivery.
Vozza G; Danish M; Byrne HJ; Frías JM; Ryan SM
Int J Pharm; 2018 Nov; 551(1-2):257-269. PubMed ID: 30153488
[TBL] [Abstract][Full Text] [Related]
23. Enhancement of oral bioavailability of poorly water soluble carvedilol by chitosan nanoparticles: Optimization and pharmacokinetic study.
Sharma M; Sharma R; Jain DK; Saraf A
Int J Biol Macromol; 2019 Aug; 135():246-260. PubMed ID: 31128197
[TBL] [Abstract][Full Text] [Related]
24. Raloxifene-encapsulated hyaluronic acid-decorated chitosan nanoparticles selectively induce apoptosis in lung cancer cells.
Almutairi FM; Abd-Rabou AA; Mohamed MS
Bioorg Med Chem; 2019 Apr; 27(8):1629-1638. PubMed ID: 30879864
[TBL] [Abstract][Full Text] [Related]
25. Preparation and characterization of rod-like chitosan-quinoline nanoparticles as pH-responsive nanocarriers for quercetin delivery.
Rahimi S; Khoee S; Ghandi M
Int J Biol Macromol; 2019 May; 128():279-289. PubMed ID: 30695722
[TBL] [Abstract][Full Text] [Related]
26. Formulation, development and optimization of raloxifene-loaded chitosan nanoparticles for treatment of osteoporosis.
Saini D; Fazil M; Ali MM; Baboota S; Ali J
Drug Deliv; 2015; 22(6):823-36. PubMed ID: 24725026
[TBL] [Abstract][Full Text] [Related]
27. Characterization and anti-proliferative activity of curcumin loaded chitosan nanoparticles in cervical cancer.
Khan MA; Zafaryab M; Mehdi SH; Ahmad I; Rizvi MM
Int J Biol Macromol; 2016 Dec; 93(Pt A):242-253. PubMed ID: 27565296
[TBL] [Abstract][Full Text] [Related]
28. Comparison in docetaxel-loaded nanoparticles based on three different carboxymethyl chitosans.
Zhang E; Xing R; Liu S; Li K; Qin Y; Yu H; Li P
Int J Biol Macromol; 2017 Aug; 101():1012-1018. PubMed ID: 28389400
[TBL] [Abstract][Full Text] [Related]
29. Sunitinib loaded chitosan nanoparticles formulation and its evaluation.
Joseph JJ; Sangeetha D; Gomathi T
Int J Biol Macromol; 2016 Jan; 82():952-8. PubMed ID: 26522243
[TBL] [Abstract][Full Text] [Related]
30. Bio-fabrication and statistical optimization of polysorbate 80 coated chitosan nanoparticles of tapentadol hydrochloride for central antinociceptive effect: in vitro-in vivo studies.
Patil GB; Surana SJ
Artif Cells Nanomed Biotechnol; 2017 May; 45(3):505-514. PubMed ID: 27017892
[TBL] [Abstract][Full Text] [Related]
31. Optimizing indomethacin-loaded chitosan nanoparticle size, encapsulation, and release using Box-Behnken experimental design.
Abul Kalam M; Khan AA; Khan S; Almalik A; Alshamsan A
Int J Biol Macromol; 2016 Jun; 87():329-40. PubMed ID: 26893052
[TBL] [Abstract][Full Text] [Related]
32. Development of rosuvastatin flexible lipid-based nanoparticles: promising nanocarriers for improving intestinal cells cytotoxicity.
Ahmed TA
BMC Pharmacol Toxicol; 2020 Feb; 21(1):14. PubMed ID: 32085802
[TBL] [Abstract][Full Text] [Related]
33. Formulation, optimization and characterization of cationic polymeric nanoparticles of mast cell stabilizing agent using the Box-Behnken experimental design.
Gajra B; Patel RR; Dalwadi C
Drug Dev Ind Pharm; 2016; 42(5):747-57. PubMed ID: 26559522
[TBL] [Abstract][Full Text] [Related]
34. Implementation of two different experimental designs for screening and optimization of process parameters for metformin-loaded carboxymethyl chitosan formulation.
De A; Kuppuswamy G; Jaiswal A
Drug Dev Ind Pharm; 2019 Nov; 45(11):1821-1834. PubMed ID: 31486683
[TBL] [Abstract][Full Text] [Related]
35. Curcumin drug delivery by vanillin-chitosan coated with calcium ferrite hybrid nanoparticles as carrier.
Kamaraj S; Palanisamy UM; Kadhar Mohamed MSB; Gangasalam A; Maria GA; Kandasamy R
Eur J Pharm Sci; 2018 Apr; 116():48-60. PubMed ID: 29355595
[TBL] [Abstract][Full Text] [Related]
36. Stimulus Responsive Ocular Gentamycin-Ferrying Chitosan Nanoparticles Hydrogel: Formulation Optimization, Ocular Safety and Antibacterial Assessment.
Alruwaili NK; Zafar A; Imam SS; Alharbi KS; Alotaibi NH; Alshehri S; Alhakamy NA; Alzarea AI; Afzal M; Elmowafy M
Int J Nanomedicine; 2020; 15():4717-4737. PubMed ID: 32636627
[TBL] [Abstract][Full Text] [Related]
37. Central composite rotatable design for optimization of budesonide-loaded cross-linked chitosan-dextran sulfate nanodispersion: characterization,
Bodas DS; Ige PP
Drug Dev Ind Pharm; 2019 Jul; 45(7):1193-1204. PubMed ID: 30983428
[TBL] [Abstract][Full Text] [Related]
38. Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy.
He Y; Su Z; Xue L; Xu H; Zhang C
J Control Release; 2016 May; 229():80-92. PubMed ID: 26945977
[TBL] [Abstract][Full Text] [Related]
39. Selective anticancer activity of hydroxyapatite/chitosan-poly(d,l)-lactide-co-glycolide particles loaded with an androstane-based cancer inhibitor.
Ignjatović NL; Penov-Gaši KM; Wu VM; Ajduković JJ; Kojić VV; Vasiljević-Radović D; Kuzmanović M; Uskoković V; Uskoković DP
Colloids Surf B Biointerfaces; 2016 Dec; 148():629-639. PubMed ID: 27694053
[TBL] [Abstract][Full Text] [Related]
40. Study of 5-Fluorouracil Loaded Chitosan Nanoparticles for Treatment of Skin Cancer.
Patel G; Yadav BKN
Recent Pat Nanotechnol; 2020; 14(3):210-224. PubMed ID: 31267881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
